Predictive Capabilities of Human Leukocyte Antigen-G and Galectin-13 Levels in the Amniotic Fluid and Maternal Blood for the Pregnancy Outcome
- PMID: 38256346
- PMCID: PMC10820789
- DOI: 10.3390/medicina60010085
Predictive Capabilities of Human Leukocyte Antigen-G and Galectin-13 Levels in the Amniotic Fluid and Maternal Blood for the Pregnancy Outcome
Abstract
Background and Objectives: Increasing evidence points to the significant role of the angiogenic factor levels in screening for pregnancy outcome. To examine the potential relationship between concentrations of placental protein 13 (PP13) and soluble human leukocyte antigen-G (sHLA-G) in maternal serum and amniotic fluid at 16-23 weeks of gestation and the sonographic features of pregnancy as well as pregnancy outcome. Materials and Methods: PP13 and sHLA-G in serum and amniotic fluid, fetal biometrical data, and placental volume and perfusion indices were determined in 71 euploid, singleton pregnancies. Results: The serum sHLA-G level exhibits a negative correlation with the serum PP13 level (r = -0.186, p < 0.001) and a positive correlation with the sHLA-G level in amniotic fluid (r = 0.662, p < 0.001). A significant correlation was found between serum sHLA-G level and placental volume (r = 0.142, p < 0.05) and between amniotic sHLA-G level and placental perfusion (r = -0.450, p < 0.001). A low amniotic PP13 level significantly predicted the birth weight (r = -0.102, p < 0.05), the duration of pregnancy (r = -0.155, p < 0.05), and the fetal abdominal circumference (r = -0.098, p < 0.05). Conclusions: PP13 assayed in amniotic fluid might be a potential marker of fetal growth, and sHLA-G can be an adjunct modality reflecting placental sonographic parameters.
Keywords: amniotic fluid; placental protein-13; serum; soluble human leukocyte antigen-G; sonography.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
Similar articles
-
Galectin-13 and Laeverin Levels Interfere with Human Fetoplacental Growth.Int J Mol Sci. 2024 Jun 8;25(12):6347. doi: 10.3390/ijms25126347. Int J Mol Sci. 2024. PMID: 38928055 Free PMC article.
-
How the Soluble Human Leukocyte Antigen-G levels in Amniotic Fluid and Maternal Serum Correlate with the Feto-Placental Growth in Uncomplicated Pregnancies.Bioengineering (Basel). 2024 May 18;11(5):509. doi: 10.3390/bioengineering11050509. Bioengineering (Basel). 2024. PMID: 38790375 Free PMC article.
-
HLA-G antigen and parturition: maternal serum, fetal serum and amniotic fluid levels during pregnancy.Fetal Diagn Ther. 2004 Sep-Oct;19(5):404-9. doi: 10.1159/000078992. Fetal Diagn Ther. 2004. PMID: 15305096
-
Placental Protein 13 (PP13) - A Placental Immunoregulatory Galectin Protecting Pregnancy.Front Immunol. 2014 Aug 20;5:348. doi: 10.3389/fimmu.2014.00348. eCollection 2014. Front Immunol. 2014. PMID: 25191322 Free PMC article. Review.
-
HLA-G in reproduction: studies on the maternal-fetal interface.Hum Immunol. 2000 Nov;61(11):1113-7. doi: 10.1016/s0198-8859(00)00195-6. Hum Immunol. 2000. PMID: 11137215 Review.
Cited by
-
Galectin-13 and Laeverin Levels Interfere with Human Fetoplacental Growth.Int J Mol Sci. 2024 Jun 8;25(12):6347. doi: 10.3390/ijms25126347. Int J Mol Sci. 2024. PMID: 38928055 Free PMC article.
-
How the Soluble Human Leukocyte Antigen-G levels in Amniotic Fluid and Maternal Serum Correlate with the Feto-Placental Growth in Uncomplicated Pregnancies.Bioengineering (Basel). 2024 May 18;11(5):509. doi: 10.3390/bioengineering11050509. Bioengineering (Basel). 2024. PMID: 38790375 Free PMC article.
-
Amniotic Fluid and Maternal Serum Laeverin Levels and Their Correlations with Fetal Size and Placental Volume in Second Trimester of Pregnancy-A Prospective Cross-Sectional Study.Diagnostics (Basel). 2025 Jan 29;15(3):317. doi: 10.3390/diagnostics15030317. Diagnostics (Basel). 2025. PMID: 39941247 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources